Two national employers select dario's integrated chronic condition solution to improve employee health

Dario selected to provide integrated approach to improve employee cardiometabolic health - including support for those taking a glp-1 medication - musculoskeletal and behavioral health new york , april 2, 2024 /prnewswire/ -- dariohealth corp. (nasdaq: drio) ("dario" or the "company"), a leader in the global digital health market, announced today two new contracts to provide integrated chronic condition management solutions for two national employers beginning in the second quarter of 2024.   the first employer, a global private investment group, selected dario's cardiometabolic suite to help improve outcomes for employees with cardiometabolic health conditions, including diabetes, pre-diabetes, hypertension and weight management needs, including support for individuals taking a glp-1.
DRIO Ratings Summary
DRIO Quant Ranking